FDA Inspection 1137255 — Berman, Gary D., MD, Clinical Investigator

Berman, Gary D., MD, Clinical Investigator — FEI 3010299470

The FDA completed an inspection of Berman, Gary D., MD, Clinical Investigator on March 29, 2021 in Minneapolis, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 29, 2021
Fiscal Year
2021
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Minneapolis, MN (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance